Cancer
Malignant Bladder Neoplasm
CI-CAN-00005866Explore in graph →
Top-level346 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer
CI-CAN-00005866Explore in graph →
Clinical trials
1,511 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (179)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04570176 | Efficacy and Safety of Clinical Telesurgery Using Chinese Independently Developed Surgical Robot System | completed | N/A | 1 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Feb 16, 2022 | clinicaltrials |
| NCT02178722 | Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers | completed | Phase 1 / Phase 2 | 444 | Incyte CorporationINDUSTRY | 1 | Feb 14, 2022 |
| clinicaltrials |
| NCT01391143 | Safety Study of MGA271 in Refractory Cancer | completed | Phase 1 | 179 | MacroGenicsINDUSTRY | 1 | Feb 8, 2022 | clinicaltrials |
| NCT04316689 | First-in-human Study of S-588210 (S-488210+S-488211) | completed | Phase 1 | 10 | ShionogiINDUSTRY | 1 | Jan 26, 2022 | clinicaltrials |
| NCT01935466 | Risk of Bladder Cancer in Type 2 Diabetes Patients With Pioglitazone Therapy "PROBE"(PROBE-PIO) | completed | — | 6,107 | Post Graduate Institute of Medical Education and Research, ChandigarhOTHER | 1 | Jan 25, 2022 | clinicaltrials |
| NCT02966691 | Evaluation of Diagnostic Performance of VisioCyt® Test, in Case of Suspicion of Urothelial Bladder Tumors(VISIOCYT 1) | completed | N/A | 1,360 | VitadxOTHER | 1 | Jan 6, 2022 | clinicaltrials |
| NCT03689478 | Use of Immediate Hyperthermic Intravesical Chemotherapy Following TURBT(I-HIVEC) | completed | N/A | 30 | Chinese University of Hong KongOTHER | 1 | Jan 3, 2022 | clinicaltrials |
| NCT02001623 | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 195 | Seagen Inc.INDUSTRY | 5 | Dec 29, 2021 | clinicaltrials |
| NCT03430895 | Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract | completed | Phase 2 | 15 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Dec 1, 2021 | clinicaltrials |
| NCT03520231 | Study Comparing Denosumab With Standard Treatment in Urothelial Cancer Patients With Bone Metastases | completed | Phase 2 | 6 | University Health Network, TorontoOTHER | 1 | Nov 23, 2021 | clinicaltrials |
| NCT04555343 | Intravesical Antifibrinolytic for Patients With Hematuria and Clot Retention | completed | Phase 1 / Phase 2 | 14 | Fraser HealthOTHER | 1 | Nov 5, 2021 | clinicaltrials |
| NCT03245736 | Tisotumab Vedotin Continued Treatment in Patients With Solid Tumors. | completed | Phase 2 | 5 | Seagen Inc.INDUSTRY | 2 | Nov 4, 2021 | clinicaltrials |
| NCT00318643 | Safety Study of Recombinant Human Hyaluronidase (Chemophase) in Combination With Mitomycin in Participants With Superficial Bladder Cancer | completed | Phase 1 / Phase 2 | 27 | Halozyme TherapeuticsINDUSTRY | 1 | Oct 29, 2021 | clinicaltrials |
| NCT01738815 | Impact of Valproate on Angiogenesis and Histone Deacetylation in Bladder Cancer | completed | Early Phase 1 | 43 | State University of New York - Upstate Medical UniversityOTHER | 1 | Oct 22, 2021 | clinicaltrials |
| NCT04190641 | Single-use Cystoscope System for Direct Visualization of the Urethra and Bladder | completed | N/A | 4 | Ambu A/SINDUSTRY | 1 | Oct 14, 2021 | clinicaltrials |
| NCT03091764 | Evaluation of a Patient-Reported Symptom Index for NMIBC | completed | — | 498 | University of SydneyOTHER | 5 | Oct 13, 2021 | clinicaltrials |
| NCT01776138 | Study of Outcomes After Surgery/Treatment to Treat Bladder Cancer(PORCH) | completed | — | 103 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04900259 | The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations | completed | — | 183 | Ankara Training and Research HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT04256161 | Measurements of Sexual Steroids' Concentrations in Prostatic Tissue(Pré-HORM) | completed | — | 24 | Hopital FochOTHER | 1 | Aug 27, 2021 | clinicaltrials |
| NCT00694915 | Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder(STCC) | completed | Phase 2 | 122 | Cadila PharnmaceuticalsINDUSTRY | 1 | Aug 17, 2021 | clinicaltrials |
| NCT01489800 | The Impact of Early Feeding After Radical Cystectomy for Bladder Cancer | completed | N/A | 102 | Columbia UniversityOTHER | 1 | Aug 17, 2021 | clinicaltrials |
| NCT01343121 | Measurement of Gemcitabine Metabolites in Blood and Urine as Predictors of Response to GemX Bladder Radiotherapy(Gemtrans) | completed | N/A | 50 | The Christie NHS Foundation TrustOTHER | 1 | Aug 13, 2021 | clinicaltrials |
| NCT04358718 | Influence of Opioids on Circulating Tumor Cells in Radical Cystectomy | completed | N/A | 44 | RenJi HospitalOTHER | 1 | Aug 9, 2021 | clinicaltrials |
| NCT03063125 | Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer | completed | — | 25 | University of Kansas Medical CenterOTHER | 1 | Aug 3, 2021 | clinicaltrials |
| NCT02252549 | An International Randomized Study to Compare SPIES Versus WLI | completed | N/A | 700 | Clinical Research Office of the Endourological SocietyOTHER | 0 | Jul 28, 2021 | clinicaltrials |
| NCT03327883 | Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer | completed | — | 15 | National Cancer Institute (NCI)NIH | 1 | Jul 9, 2021 | clinicaltrials |
| NCT04601766 | A Phase I, Two-phase, Crossover Study to Evaluate the Safety, Tolerability and Pharmacokinetics of APL-1501 ER Tablets | completed | Phase 1 | 12 | Asieris Pharmaceuticals (AUS) Pty Ltd.INDUSTRY | 1 | Jun 30, 2021 | clinicaltrials |
| NCT02340650 | High Resolution Imaging for Early and Better Detection of Bladder Cancer(HRME_Bladder) | completed | — | 37 | The University of Texas Health Science Center, HoustonOTHER | 1 | Jun 25, 2021 | clinicaltrials |
| NCT02852252 | Solid Tumor Cancer Surgery With or Without Intraoperative Imaging: A Registry | completed | — | 291 | University of PennsylvaniaOTHER | 1 | Jun 18, 2021 | clinicaltrials |
| NCT02298998 | Surveillance for Low and Low-Intermediate Risk Non-muscle Invasive Bladder Cancer: A Pilot Study | completed | — | 41 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 14, 2021 | clinicaltrials |
| NCT00118040 | Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer | completed | Phase 2 | 60 | National Cancer Institute (NCI)NIH | 1 | Jun 10, 2021 | clinicaltrials |
| NCT02009332 | Phase 1/2 Study of ABI-009 in Nonmuscle Invasive Bladder Cancer | completed | Phase 1 / Phase 2 | 21 | Aadi Bioscience, Inc.INDUSTRY | 1 | Jun 8, 2021 | clinicaltrials |
| NCT04885309 | Efficacy and Safety of Obturator Nerve Block During Transurethral Resection on Non-muscle Invasive Intermediate and High Risk Lateral Wall Bladder Tumours | completed | N/A | 104 | Ankara Training and Research HospitalOTHER | 1 | May 13, 2021 | clinicaltrials |
| NCT01827943 | Phase II Evaluating Efficacy of Temsirolimus in 2 Line Therapy for Patients With Advanced Bladder Cancer(VESTOR) | completed | Phase 2 | 54 | Institut BergoniéOTHER | 1 | May 6, 2021 | clinicaltrials |
| NCT02647112 | Utility of Bladder EpiCheck for Detection of Recurrent Urothelial Carcinoma | completed | N/A | 1,050 | Nucleix Ltd.INDUSTRY | 4 | May 4, 2021 | clinicaltrials |
| NCT02700464 | The Efficacy of the Bladder EpiCheck for Detection of Recurrent Urothelial Cell Carcinoma | completed | N/A | 680 | Nucleix Ltd.INDUSTRY | 2 | May 4, 2021 | clinicaltrials |
| NCT04872036 | Prognostic Biomarkers in Patients With Urothelial Carcinoma | completed | — | 66 | Hellenic Cooperative Oncology GroupOTHER | 0 | May 4, 2021 | clinicaltrials |
| NCT03257293 | A Trial of a Modified Cystoscopy Method to Reduce Pain Perception | completed | N/A | 93 | Western University, CanadaOTHER | 1 | Apr 27, 2021 | clinicaltrials |
| NCT02365818 | Safety and Efficacy of CG0070 Oncolytic Virus Regimen for High Grade NMIBC After BCG Failure(BOND2) | completed | Phase 2 | 66 | CG Oncology, Inc.INDUSTRY | 1 | Apr 14, 2021 | clinicaltrials |
| NCT04838873 | Trial of Open Versus Laparoscopic Radical Cystectomy at a Laparoscopic Naive Center | completed | N/A | 60 | Cairo UniversityOTHER | 1 | Apr 9, 2021 | clinicaltrials |
| NCT02552121 | Tisotumab Vedotin (HuMax®-TF-ADC) Safety Study in Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 33 | Seagen Inc.INDUSTRY | 5 | Apr 8, 2021 | clinicaltrials |
| NCT00461591 | Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-611) | completed | Phase 3 | 802 | Spectrum Pharmaceuticals, IncINDUSTRY | 1 | Mar 30, 2021 | clinicaltrials |
| NCT03063255 | Comparison of Obturator Nerve Blockade and Neuromuscular Blockade | completed | Phase 4 | 60 | University of FloridaOTHER | 1 | Mar 24, 2021 | clinicaltrials |
| NCT02753309 | A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer | completed | Early Phase 1 | 33 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Mar 19, 2021 | clinicaltrials |
| NCT02880176 | Steps to Eliminate Postoperative Problems(STEPP) | completed | N/A | 34 | University of PennsylvaniaOTHER | 1 | Mar 9, 2021 | clinicaltrials |
| NCT02800473 | Validation of Endoscopic Bimodal Imager for the Bladder Cancer Detection(CyPaM2) | completed | N/A | 10 | Institut de Cancérologie de LorraineOTHER | 1 | Mar 8, 2021 | clinicaltrials |
| NCT04334226 | The Impact of Preoperative Urostomy Education on Patients and Families(StomABC Impact) | completed | — | 16 | University of Kansas Medical CenterOTHER | 1 | Mar 4, 2021 | clinicaltrials |
| NCT04768894 | Impact of Time to Re-staging Transurethral Resection on Recurrence and Progression Rates | completed | N/A | 109 | Saglik Bilimleri UniversitesiOTHER | 0 | Feb 26, 2021 | clinicaltrials |
| NCT02897765 | A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer | completed | Phase 1 | 34 | BioNTech US Inc.INDUSTRY | 1 | Feb 25, 2021 | clinicaltrials |
| NCT03125226 | TracelT Hydrogel in Localizing Bladder Tumors in Patients Undergoing Radiation Therapy for Bladder Cancer | completed | N/A | 12 | University of WashingtonOTHER | 1 | Feb 25, 2021 | clinicaltrials |
Data updated 23 days agoSource updated Feb 16, 2022source: clinicaltrials